Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
Three weeks of higher dose radiation worked as well as the standard-dose, five-week schedule after a lumpectomy for invasive, lymph node-negative disease, study shows.
New standards for ER, PR tests in breast cancer have been released by American Society of Clinical Oncology and College of American Pathologists.
Herceptin-based treatments without anthracyclines caused fewer cases of heart failure than treatments containing anthracyclines, study at San Antonio Symposium shows.
Increased access to treatment and follow-up care, protection of coverage in case of job change or loss, ensuring coverage despite pre-existing conditions and increasing quality and quantity of life for young women are among the ways the healthcare overhaul bill may impact people with a history of breast cancer.
A body mass index of more than 25 (being overweight or obese) is related to metastatic recurrence and poorer survival rates in women who have had breast cancer, according to results released at the San Antonio Breast Cancer Symposium.
Lapatinib plus Trastuzumab was more effective than Lapatinib alone for women with HER2 positive advanced breast cancer that progressed on trastuzumab, San Antonio study shows.
Prophylactic mastectomy is recommended only for women at high risk for developing breast cancer, according to new NCCN guidelines.
This list will help you talk with your doctor or nurse about whether being part of a breast cancer clinical trial or treatment research study is right for you.
Four studies presented at the San Antonio Breast Cancer Symposium looked at existing therapies being tested in unique ways as the landscape of acceptable treatment and management of breast cancer continues to shift.
A further connection between lifestyle factors and breast cancer is revealed in two new studies presented during the San Antonio Breast Cancer Symposium.